Pediatric clinical trials exist because children are not small adults. Drugs metabolize differently in developing bodies; doses calibrated for adults may be too high, too low, or produce entirely different effects in children. Without trials specifically designed for pediatric populations, drugs are prescribed to children based on adult data — a practice that has caused serious harm historically. Pediatric trials close a real gap in medical knowledge.
Consent and assent: two different things
In pediatric trials, the parent or legal guardian provides consent — the formal legal permission. But most trials also require the child's assent — a documented acknowledgment from the child that they understand what's happening and are willing to participate, expressed in age-appropriate language.
Assent requirements vary by age. For very young children, assent isn't possible or required. For children roughly 7 and older, most IRBs require some form of assent process, using language and materials designed for the child's developmental level. For teenagers, the assent process looks much closer to adult consent.
Practically, this means both you and your child will be part of the consent conversation. The team will speak to your child directly, explain what will happen, and ask whether they're willing. A child's refusal doesn't automatically override parental consent — but it's taken seriously and often results in the team declining to enroll that child.
What makes pediatric trials different in practice
Pediatric trials tend to have more flexible visit scheduling than adult trials, with more accommodation for school schedules. Many are designed around children's routines, with visits planned outside school hours where possible. Ask about this early — it's a practical consideration that matters for your family's ability to participate.
The safety monitoring in pediatric trials is typically more intensive than in comparable adult studies. Children's physiology changes rapidly, and the study team will watch more closely for anything unexpected. This means more visits and more blood draws, which is worth knowing before you commit.
Child life specialists — professionals trained to support children through medical procedures — are available at most major pediatric study sites. Ask whether one will be involved in your child's visits. For younger children especially, their presence makes a meaningful difference.
Questions that are specific to pediatric participation
Beyond the standard questions any participant should ask, add these for a pediatric trial:
What is the age range of other participants enrolled? If your 4-year-old is being enrolled in a trial that's primarily enrolling 12-year-olds, ask why — the pharmacokinetics and safety profiles may be different enough to matter.
How will you handle procedures if my child becomes distressed? What sedation or comfort options are available for blood draws and other procedures?
What will you tell my child if something unexpected happens — and how?
If my child reaches adolescence during the trial, does their consent status change?
Your right to withdraw your child
Everything that applies to adult withdrawal rights applies here — and then some. As the consent-giving parent, you can withdraw your child at any time. Your child can also express unwillingness to continue at any point, and that expression carries weight regardless of your position. The study team is obligated to respond to a child's distress, not override it.
This isn't a reason to be anxious about the process. It's a reason to feel confident entering it.